The pooled HR (HR=2.77, 95 % CI=1.34-5.72, P=0.006) for OS showed that MM patients with high level of the p16 hypermethylation have significantly shorter survival (Figure 4). The gene discussed is CDKN2A; the disease is Miyoshi myopathy.